{"id":"https://openalex.org/W4415768014","doi":"https://doi.org/10.1007/s11523-025-01184-y","title":"The Efficacy and Safety of Beta-blockers and Immune Checkpoint Inhibitors in Patients with Cancer: A Systematic Review and Meta-analysis","display_name":"The Efficacy and Safety of Beta-blockers and Immune Checkpoint Inhibitors in Patients with Cancer: A Systematic Review and Meta-analysis","alternate_titles":[],"publication_year":2025,"publication_date":"2025-11-01","ids":{"openalex":"https://openalex.org/W4415768014","doi":"https://doi.org/10.1007/s11523-025-01184-y","pmid":"https://pubmed.ncbi.nlm.nih.gov/41176581","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12669259"},"language":"en","primary_location":{"id":"doi:10.1007/s11523-025-01184-y","doi":"https://doi.org/10.1007/s11523-025-01184-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11523-025-01184-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11523-025-01184-y.pdf","source":{"id":"https://openalex.org/S163958984","display_name":"Targeted Oncology","issn_l":"1776-2596","issn":["1776-2596","1776-260X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Targeted Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4415768014"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s11523-025-01184-y.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Kota Tokunaga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124875","display_name":"Fujita Health University Hospital","ror":"https://ror.org/02r3zks97","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210124875"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kota Tokunaga","raw_affiliation_strings":["Fujita Health University Hospital, Toyoake, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fujita Health University Hospital, Toyoake, Japan","institution_ids":["https://openalex.org/I4210124875"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077041613","display_name":"Yu Fujiwara","orcid":"https://orcid.org/0000-0003-1406-2352","observed_orcids":["https://orcid.org/0000-0003-1406-2352"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]},{"id":"https://openalex.org/I4400009020","display_name":"Institute of Science Tokyo","ror":"https://ror.org/05dqf9946","country_code":"JP","type":"education","lineage":["https://openalex.org/I4400009020"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Yu Fujiwara","raw_affiliation_strings":["Department of Clinical Oncology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan","Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan","institution_ids":["https://openalex.org/I4400009020"]},{"raw_affiliation_string":"Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109655611","display_name":"Reo Omori","orcid":"https://orcid.org/0009-0004-6005-8690","observed_orcids":["https://orcid.org/0009-0004-6005-8690"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Reo Omori","raw_affiliation_strings":["Department of Medical Oncology, Kobe City General Hospital, Kobe, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Kobe City General Hospital, Kobe, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102878448","display_name":"Takumi Sato","orcid":"https://orcid.org/0009-0009-2290-2164","observed_orcids":["https://orcid.org/0009-0009-2290-2164"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Takumi Sato","raw_affiliation_strings":["Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, Morningside and West, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, Morningside and West, New York, NY, USA","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035416012","display_name":"Manmeet Singh Ahluwalia","orcid":"https://orcid.org/0000-0003-3794-9511","observed_orcids":["https://orcid.org/0000-0003-3794-9511"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manmeet Singh Ahluwalia","raw_affiliation_strings":["Department of Medical Oncology, Miami Cancer Institute, 8900 North Kendall Drive, Miami, FL, 33176, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Miami Cancer Institute, 8900 North Kendall Drive, Miami, FL, 33176, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090466020","display_name":"Sarbajit Mukherjee","orcid":"https://orcid.org/0000-0003-2153-3896","observed_orcids":["https://orcid.org/0000-0003-2153-3896"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Sarbajit Mukherjee","raw_affiliation_strings":["Department of Medical Oncology, Miami Cancer Institute, 8900 North Kendall Drive, Miami, FL, 33176, USA. Sarbajit.Mukherjee@baptisthealth.net","Department of Medical Oncology, Miami Cancer Institute, 8900 North Kendall Drive, Miami, FL, 33176, USA"],"raw_orcid":"https://orcid.org/0000-0003-2153-3896","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Miami Cancer Institute, 8900 North Kendall Drive, Miami, FL, 33176, USA. Sarbajit.Mukherjee@baptisthealth.net","institution_ids":[]},{"raw_affiliation_string":"Department of Medical Oncology, Miami Cancer Institute, 8900 North Kendall Drive, Miami, FL, 33176, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5090466020"],"corresponding_institution_ids":[],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":{"value":4990,"currency":"USD","value_usd":4990},"fwci":1.8044,"has_fulltext":true,"cited_by_count":18,"citation_normalized_percentile":{"value":0.86229849,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"20","issue":"6","first_page":"893","last_page":"905"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12626","display_name":"Cancer, Stress, Anesthesia, and Immune Response","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11296","display_name":"COVID-19 and healthcare impacts","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":1.0},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7319999933242798},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.9879999756813049},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9440000057220459},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":1.0},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7850000262260437},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7310000061988831},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4059999883174896}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.97079998254776},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5317000150680542},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5286999940872192},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44029998779296875},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.41130000352859497},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.39160001277923584},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3878999948501587},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3865000009536743},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.38029998540878296},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.3562999963760376},{"id":"https://openalex.org/C2908856526","wikidata":"https://www.wikidata.org/wiki/Q16252627","display_name":"Antibody therapy","level":4,"score":0.33250001072883606},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.33090001344680786},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3206000030040741},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.31279999017715454},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3093000054359436},{"id":"https://openalex.org/C169382597","wikidata":"https://www.wikidata.org/wiki/Q21208025","display_name":"Programmed cell death 1","level":5,"score":0.30079999566078186},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.26010000705718994}],"mesh":[{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1007/s11523-025-01184-y","doi":"https://doi.org/10.1007/s11523-025-01184-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11523-025-01184-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11523-025-01184-y.pdf","source":{"id":"https://openalex.org/S163958984","display_name":"Targeted Oncology","issn_l":"1776-2596","issn":["1776-2596","1776-260X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Targeted Oncology","raw_type":"journal-article"},{"id":"pmid:41176581","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41176581","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Targeted oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12669259","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12669259/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Target Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1007/s11523-025-01184-y","doi":"https://doi.org/10.1007/s11523-025-01184-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11523-025-01184-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11523-025-01184-y.pdf","source":{"id":"https://openalex.org/S163958984","display_name":"Targeted Oncology","issn_l":"1776-2596","issn":["1776-2596","1776-260X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Targeted Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4415768014.pdf","grobid_xml":"https://content.openalex.org/works/W4415768014.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W1831967008","https://openalex.org/W1882271490","https://openalex.org/W1947924801","https://openalex.org/W2116475791","https://openalex.org/W2141382054","https://openalex.org/W2566106732","https://openalex.org/W2748524892","https://openalex.org/W2768592202","https://openalex.org/W2889950184","https://openalex.org/W2922278286","https://openalex.org/W2957658998","https://openalex.org/W2978526767","https://openalex.org/W2980715209","https://openalex.org/W2990165942","https://openalex.org/W2996605404","https://openalex.org/W3012177200","https://openalex.org/W3012297006","https://openalex.org/W3029246561","https://openalex.org/W3036050630","https://openalex.org/W3039484069","https://openalex.org/W3047474087","https://openalex.org/W3095647733","https://openalex.org/W3096139666","https://openalex.org/W3100889310","https://openalex.org/W3123893780","https://openalex.org/W3143467719","https://openalex.org/W3155656454","https://openalex.org/W3187798854","https://openalex.org/W3204797275","https://openalex.org/W4206697973","https://openalex.org/W4213440518","https://openalex.org/W4283811790","https://openalex.org/W4288176171","https://openalex.org/W4293496788","https://openalex.org/W4307488641","https://openalex.org/W4320712553","https://openalex.org/W4320731361","https://openalex.org/W4365810952","https://openalex.org/W4386886545","https://openalex.org/W4389391511","https://openalex.org/W4390839244"],"related_works":["https://openalex.org/W4416266631","https://openalex.org/W4307488641","https://openalex.org/W3031948119","https://openalex.org/W7162688433","https://openalex.org/W4293496788","https://openalex.org/W4415373256","https://openalex.org/W4413030952","https://openalex.org/W7162567861","https://openalex.org/W3047474087","https://openalex.org/W3130175388"],"abstract_inverted_index":{"Immune":[0],"checkpoint":[1],"inhibitors":[2],"(ICIs)":[3],"are":[4],"now":[5],"standard":[6],"for":[7,66,72,197,210,223],"various":[8],"cancers,":[9],"and":[10,39,55,62,87,128,130,140,186,214],"preclinical":[11,241],"studies":[12,25,67,113],"suggest":[13],"beta-blockers":[14],"(BBs)":[15],"may":[16],"boost":[17],"the":[18,37,194,259],"efficacy":[19,38],"of":[20,41,60,80,138,229,261],"ICIs.":[21],"However,":[22],"prior":[23],"clinical":[24,112],"had":[26],"small":[27],"sample":[28],"sizes,":[29],"requiring":[30],"large-scale":[31],"validation.":[32],"We":[33,257],"aimed":[34],"to":[35,76,236,249],"evaluate":[36],"safety":[40],"combining":[42],"BBs":[43,69,127,139,230,248],"with":[44,48,92,103,117,122,145,254],"ICIs":[45,71,129,134,141,232,250],"in":[46,193],"patients":[47,116,124,132],"solid":[49,73,118],"tumors":[50,74,119],"through":[51],"a":[52,99,146],"systematic":[53,58],"review":[54],"meta-analysis.":[56],"A":[57],"search":[59],"PubMed/MEDLINE":[61],"Embase":[63],"was":[64,142,251],"conducted":[65],"on":[68],"plus":[70,231],"up":[75],"July":[77],"2024.":[78],"Outcomes":[79],"interest":[81],"were":[82,96,120],"overall":[83,148,198],"survival,":[84,86],"progression-free":[85,165],"adverse":[88],"events.":[89],"Hazard":[90],"ratios":[91,196],"95%":[93,153,170],"confidence":[94,154,171],"intervals":[95],"pooled":[97],"using":[98],"random-effects":[100],"model":[101],"meta-analysis,":[102],"heterogeneity":[104,192,211,224],"assessed":[105],"by":[106,183],"I":[107,160,177,205,218],"2":[108,161,178,206,219],"statistics.":[109],"Overall,":[110],"12":[111],"involving":[114],"4293":[115],"included,":[121],"1463":[123],"receiving":[125,133],"both":[126],"2830":[131],"alone.":[135],"The":[136,227],"combination":[137,228],"not":[143,234,252],"associated":[144,253],"longer":[147,255],"survival":[149,166,199],"(hazard":[150,167],"ratio":[151,168],"1.02;":[152],"interval":[155,172],"0.84\u20131.23;":[156],"p":[157,174,209,222],"=":[158,162,175,179,207,212,220,225],"0.87;":[159],"69%)":[163],"or":[164],"0.98;":[169],"0.80\u20131.20;":[173],"0.81;":[176],"71%).":[180],"Subgroup":[181],"analyses":[182],"cancer":[184,202],"types":[185,188,203,216],"BB":[187,215],"showed":[189,245],"no":[190],"significant":[191],"hazard":[195],"across":[200],"different":[201],"(":[204,217],"0%,":[208,221],"0.44)":[213],"0.67).":[226],"did":[233],"seem":[235],"increase":[237],"toxicity.":[238],"Despite":[239],"positive":[240],"findings,":[242],"this":[243,266],"meta-analysis":[244],"that":[246],"adding":[247],"survival.":[256],"await":[258],"results":[260],"ongoing":[262],"prospective":[263],"trials":[264],"assessing":[265],"strategy.":[267],"CRD42024574043.":[268]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4415768014","counts_by_year":[{"year":2026,"cited_by_count":18}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2025-11-01T00:00:00"}
